Xinrong Best Medical Instrument Co., one of China's leading manufacturers of orthopedic implants for trauma, spine, and joint applications, has hired Yu (Christine) Zhang as CEO following Blackstone's investment.

She was previously director of Stryker's China business. Her tenure spanned nearly eight years and included several leadership positions in the orthopedics and medsurg franchises. Zhang has nearly 20 years of experience in the medical device and pharmaceutical industries with a strong track record for driving business results.

In September this year, funds managed by global asset manager Blackstone made a significant investment into Xinrong.